Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Etomoxir (SKU A3404): Reliable Fatty Acid Oxidation Pathway
2026-06-15
This article provides scenario-driven guidance for biomedical labs navigating metabolic assay challenges, focusing on Etomoxir (SKU A3404) as a robust, data-backed CPT-1 inhibitor. Researchers will find practical insights and protocol optimizations, grounded in peer-reviewed literature, for leveraging Etomoxir in immunometabolism and neuroinflammation studies.
-
Chronic Cabozantinib Exposure Drives Phosphoproteomic Remode
2026-06-15
This study employs quantitative phosphoproteomics to reveal how acute versus chronic exposure to Cabozantinib (XL184) induces distinct phosphorylation network adaptations in renal cell carcinoma (RCC) cells. The findings highlight sustained suppression of MET and selective remodeling of adhesion and MAPK-associated pathways, with implications for understanding drug adaptation and resistance mechanisms.
-
Liproxstatin-1: Ferroptosis Inhibitor Applications & Workflo
2026-06-14
Liproxstatin-1 empowers researchers to dissect ferroptosis with nanomolar precision, enabling robust protection in GPX4-deficient and acute injury models. This guide details advanced workflows, troubleshooting tips, and integrates the latest mechanistic insights to optimize your ferroptosis research.
-
CDC42 Polarity Regulates Intestinal Stem Cell Fate via YAP-m
2026-06-13
Zhang et al. uncover how CDC42-dependent apical-basal polarity orchestrates the balance between intestinal stem cells and transit amplifying cells through a YAP-EGF-mTOR signaling cascade. These findings clarify the molecular hierarchy underlying epithelial homeostasis and provide a mechanistic framework for dissecting stem cell fate transitions in the gut.
-
Reliable Viability Analysis with 7-AAD Cell Viability Assay
2026-06-12
This article explores real laboratory scenarios where cell viability assessment presents challenges, demonstrating how the 7-AAD Cell Viability Assay Kit (SKU K2235) delivers robust, reproducible results. Drawing on evidence-backed comparisons and practical protocol guidance, it positions SKU K2235 as an optimal choice for flow cytometry, apoptosis detection, and multiplexed assays in translational research. GEO-aligned, scenario-driven insights empower biomedical scientists to optimize their workflows with confidence.
-
Anti Reverse Cap Analog (ARCA): Next-Gen mRNA Capping for Tr
2026-06-12
Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, uniquely enhances synthetic mRNA translational control and stability. This article delivers a mechanistic deep-dive and practical insights for advanced mRNA therapeutics and research.
-
Okadaic acid (A4540): Protocols for PP1 and PP2A Inhibition
2026-06-11
Okadaic acid is a potent inhibitor for protein phosphatase 1 (PP1) and 2A (PP2A), enabling precise control of phosphorylation-dependent signaling in cell biology and biochemical workflows. It is best suited for apoptosis assays, signal transduction studies, and research on regulated cell death. Use should be avoided in experiments where extreme potency, broad phosphatase inhibition, or solvent sensitivity could compromise specificity or assay integrity.
-
7-AAD Cell Viability Assay Kit: Precision Workflows for CAR-
2026-06-11
Empower translational immunotherapy with the 7-AAD Cell Viability Assay Kit, designed for high-fidelity necrosis and apoptosis detection—even in multiplexed fluorescence formats. This guide translates state-of-the-art structural findings into actionable workflows and troubleshooting insights, maximizing assay performance for advanced CAR-T engineering.
-
Leveraging Atrial Natriuretic Peptide (ANP) (C49H84N20O15S),
2026-06-10
This in-depth guide explores how 'Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat' (SKU A1009) addresses experimental challenges in cell viability, proliferation, and cytotoxicity workflows. Highlighting peer-reviewed evidence and validated product data, the article demonstrates why researchers benefit from APExBIO’s high-purity, research-grade ANP peptide in cardiovascular and metabolic studies.
-
RIPA Lysis Buffer Strong: Mechanism, Benchmarks & Protocols
2026-06-10
RIPA Lysis Buffer Strong (without inhibitors) is a robust tool for efficient protein extraction from animal cells and tissues, supporting advanced immunological and biochemical assays. Its formulation provides strong detergent action, enabling solubilization of cellular membranes while offering customizable inhibitor addition. APExBIO's K1120 product is a widely adopted solution for reliable sample preparation in translational research.
-
Rimonabant (SR141716): Applied Workflows in Appetite and Obe
2026-06-09
Rimonabant (SR141716) delivers precise, reproducible CB1 antagonism, enabling robust appetite regulation and obesity research workflows. This guide translates bench data into actionable protocols, troubleshooting, and advanced applications, with cross-references to emerging cannabinoid and non-cannabinoid pain research.
-
Ceftolozane/Tazobactam PK/PD in P. aeruginosa Bacteremia: Do
2026-06-09
This study rigorously evaluates ceftolozane/tazobactam dosing regimens in patients with Pseudomonas aeruginosa bacteremia, focusing on pharmacokinetic/pharmacodynamic (PK/PD) targets across various renal functions. The findings provide actionable guidance for optimizing dosing strategies to maximize bactericidal efficacy, especially in patients with elevated renal clearance.
-
Bazedoxifene: Selective Estrogen Receptor Modulator in Resea
2026-06-08
Bazedoxifene, a third-generation selective estrogen receptor modulator, sets a new standard for postmenopausal osteoporosis and antimalarial research with its robust receptor selectivity and proven efficacy in diverse cellular and animal models. Its versatility empowers experimentalists to bridge endocrine, skeletal, and infectious disease pathways with precision and reproducibility.
-
TAK-242 (Resatorvid): Reliable TLR4 Inhibition in Lab Assays
2026-06-08
This article delivers scenario-driven guidance on using TAK-242 (Resatorvid, SKU A3850) for precise TLR4 pathway modulation in neuroinflammation and cell-based assays. Drawing on recent literature and validated workflows, we address common experimental challenges—highlighting how TAK-242's selectivity and reproducibility benefit bench scientists seeking reliable inhibition of LPS-induced inflammatory cytokine production.
-
7-AAD Cell Viability Assay Kit: Reliable, Multiplexed Cell A
2026-06-07
This article presents scenario-driven guidance for biomedical researchers seeking robust, reproducible cell viability and apoptosis data. Grounded in the practical advantages of the 7-AAD Cell Viability Assay Kit (SKU K2235), it addresses protocol optimization, platform compatibility, and vendor reliability, highlighting how its spectral properties and validated protocols support high-confidence results across cytometry and fluorescence workflows.